Presented by Newstalk's Business Editor Joe Lynam, this 30-minute programme focuses on the key business stories from home and abroad, market analysis, new business innovations and profile interviews. Listen and subscribe to Breakfast Business with Joe Lynam on Apple Podcasts and Spotify. Download, listen and subscribe on the Newstalk App. You can also listen to Newstalk live on newstalk.com or on Alexa, by and asking: 'Alexa, play Newstalk'
3 days ago - 10 mins
Breakfast Business with Joe Lynam
3 days ago - 6 mins
Breakfast Business with Joe Lynam
3 days ago - 8 mins
Breakfast Business with Joe Lynam
4 days ago - 4 mins
Breakfast Business with Joe Lynam
4 days ago - 7 mins
Breakfast Business with Joe Lynam
4 days ago - 7 mins
Breakfast Business with Joe Lynam
Danish company Novo Nordisk came up with a revolutionary weight loss drug called Wegovy and Ozempic. Its rival Eli Lilly has Mounjaro and Pfizer is looking at developing one too. Now another Scandinavian pharmaceutical group Pila Pharma thinks it may have found another weight loss pill too. Speaking to Joe this morning was Gustav Gram, the Chief Executive of Pila Pharma.